ATACANDHCT Trademark

Trademark Overview

On Tuesday, April 19, 2005, a trademark application was filed for ATACANDHCT with the United States Patent and Trademark Office. The USPTO has given the ATACANDHCT trademark a serial number of 78611911. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 4, 2018. This trademark is owned by AstraZeneca AB. The ATACANDHCT trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
atacandhct

General Information

Serial Number78611911
Word MarkATACANDHCT
Filing DateTuesday, April 19, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 4, 2018
Registration Number3303664
Registration DateTuesday, October 2, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateTuesday, February 28, 2006
First Use In Commerce DateTuesday, February 28, 2006

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151 85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151 85
SE

Trademark Events

Event DateEvent Description
Friday, May 4, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, October 2, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 2, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 2, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 2, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 22, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 2, 2007REGISTERED-PRINCIPAL REGISTER
Monday, August 27, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 27, 2007ASSIGNED TO LIE
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 17, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 16, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, April 13, 2007USE AMENDMENT FILED
Friday, April 13, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, April 10, 2007EXTENSION 2 GRANTED
Tuesday, April 10, 2007EXTENSION 2 FILED
Tuesday, April 10, 2007TEAS EXTENSION RECEIVED
Monday, October 16, 2006EXTENSION 1 GRANTED
Friday, September 15, 2006EXTENSION 1 FILED
Friday, September 15, 2006TEAS EXTENSION RECEIVED
Tuesday, April 11, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2005NOTICE OF PUBLICATION
Wednesday, December 7, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 18, 2005ASSIGNED TO LIE
Thursday, November 17, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 17, 2005ATTORNEY REVIEW COMPLETED
Thursday, November 17, 2005EXAMINERS AMENDMENT E-MAILED
Thursday, November 17, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 16, 2005ASSIGNED TO EXAMINER
Thursday, July 14, 2005PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, July 14, 2005PAPER RECEIVED
Wednesday, April 27, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

atacandhct diseases cardiovascular treatment preparations pharmaceutical